A new cadre of healthcare marketing firms sprang up several years ago with a vision to reshape the pharma commercialization landscape.
Leveraging infusions from private equity to buy up smaller agencies, they built out all the components for launch success. These ranged from market access, med-comms and med-ed to advertising, patient engagement and data/analytics. As such, they’ve earned the “strategics” label, right alongside their counterparts at traditional agency holding companies, Medical Marketing Media reports.
Now, this burgeoning group itself is due for a refresh, as their backers seek to cash out on those bets. Read more.
